Headlines Expert Newsletters Covid-19 Specialties Trending Feeds Videos

This editorial refers to ‘Uric acid and sodium-glucose cotransporter-2 inhibition with empagliflozin in heart failure with reduced ejection fraction: the...

AbstractAims. Hyperlipidaemia and inflammation jointly contribute to atherosclerotic disease. Yet, after the initiation of statin therapy, the relative...

Abstract Mitral annular calcification (MAC) is a common clinical finding and is associated with adverse clinical outcomes, but the clinical impact of MAC-related mitral...

This study showed that a history of premature menopause and early menopausal age was associated with an increased risk of both heart failure and...

: In observational studies, lower serum vitamin D3 (VitD3) concentration has been associated with increased risk of cardiovascular disease. However, the associations between serum...

AbstractAims. Aortic stenosis (AS) and cardiac amyloidosis (CA) frequently coexist but the diagnosis of CA in AS patients remains a diagnostic challenge. We...

AbstractAims. Randomized controlled trials have demonstrated the efficacy of mineralocorticoid receptor (MR) antagonism in delaying chronic kidney disease...

Patients with echo findings that fall outside the norm may merit closer follow-up than what the guidelines...

The findings underscore the need to ask female cardiology patients for their full reproductive history, says Sadiya...

Mashup Score:11

TCTMD

The EMPEROR-Preserved Trial - 5 days

Mashup Score:11

C. Michael Gibson and Stefan Anker discuss the effects of empagliflozin on CV death and HF hospitalizations in patients with HFpEF, with and without...